Position
Squarepoint Ops LLC in Immuneering Corp
Back to the book · All holders of IMRX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$120.9K$6.58 → $5.27
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 92.3K | $607K | — | — | — | 0.0% |
| Q1 2026 | 226K | $1.19M | $5.27 | −$120.9K | $705.1K | 0.0% |